CSE Interview with Rob Abenante CEO of Abattis Bioceuticals Corp.

0

Share

Other News

Comfort Launch by Vergence Naturals Exceeds Expectations December 11, 2018
Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018 December 10, 2018
Abattis Announces Acquisition of Fertilizer Company Nutrivida December 7, 2018
Abattis Bioceuticals Comments on BCSC Temporary Order November 28, 2018
Abattis Bioceuticals Celebrates Release of Comfort through Vergence Naturals November 27, 2018

Abattis Bioceuticals is a life sciences and biotechnology company that aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry in Canada.

Exchange Listings
CSE: ATT | OTC: ATTBF

Subscribe To Our News List
Sign up to receive alerts on Abattis news releases and product announcements

Email:

Abattis Bioceuticals Corporation
#1200 - 625 Howe Street
Vancouver, BC | V6C 2T6
T: (808) 650-3007

Follow @abattis

Legal
Privacy
Terms of Use
Terms of Service
Return Policy